Sen. Kohl fights for more FDA funding
This article was originally published in The Tan Sheet
FDA would receive $275 million additional funding this year to address import safety oversight, improve its information technology systems and implement new safety initiatives under an amendment Sen. Herb Kohl, D-Wis., chairman of the FDA appropriations subcommittee, added to the fiscal 2008 emergency war funding/supplemental appropriations bill passed by the House, H.R. 2764. The bill is slated for May 15 Senate Appropriations Committee markup. Of the total, $100 million is allocated to drug and medical device safety activities, $125 million will go to food safety activities and $40 million will be put towards modernizing FDA science and its workforce, issues considered at an April committee hearing ("The Tan Sheet," April 21, 2008, p. 5). Kohl said the additional funding would support efforts including opening two FDA offices overseas; implementing pediatric drug safety; and hiring 99 medical product safety inspectors...
You may also be interested in...
FDA could absorb an additional $100 million in funding over that proposed by the Bush Administration for fiscal 2009, but not the full $375 million recommended by the FDA Science Board, Commissioner Andrew von Eschenbach tells the Senate Appropriations Committee at an April 15 hearing. "We could absorb the $100 million that you referred to, and do that quite rapidly and quite effectively," he told the panel. "As we would get closer and closer to the [$375 million] ... it would require greater stewardship to be sure we could implement those dollars as rapidly and effectively as we need to," he said. The administration's proposal provides a $51 million increase over 2008 in direct appropriations to FDA, bringing federal funding to $1.77 billion in FY 2009 (1"The Pink Sheet," Feb. 11, 2008, p. 4). "It may be our responsibility to fix OMB's mistake here. And you probably have more friends here than you might have at other places in town," Sen. Robert Bennett, R-Utah., told the commissioner. An amendment sponsored by Sen. Ted Kennedy, D-Mass., would increase FDA appropriations according to the Science Board's recommendations for a $375 million increase over fiscal 2008 in direct appropriations to FDA for 2009, and larger increases in each of the following five years (2"The Pink Sheet," March 3, 2008, p. 9)
Notified bodies’ efforts to enhance a harmonized approach to remote audits have failed, raising questions about whether there is any avenue left to get vital devices certified by the 26 May EU MDR deadline.
As Amneal’s generics segment sees significant growth, the company has revealed plans to launch new products and expand in new markets. “We are extremely proud of the progress our company has made since we re-joined as leaders of Amneal,” said Chirag and Chintu Patel, co-CEOs of Amneal.